INTRODUCTION
A portion of the red cells (the complement-sensitive population) of patients with paroxysmal nocturnal hemoglobinuria (PNH)1 are abnormal in that they are lysed more readily than normal cells in vitro by complement (1) . At least five different procedures inducing the activation of complement have been used to detect these abnormal cells: acidification of normal serum (Ham test) (2) , reduction in ionic strength of normal serum (sucrose lysis test) (3), activation of complement by specific antibody (4), activation of complement by a 'Abbreviations used in this paper: AET, aminoethylisothiouronium bromide; alternate pathway, the mechanism of activation of the terminal components of complement which does not require the activation of C1, C4, and C2 but which depends upon the activation of properdin and other proteins in serum, including C3 proactivator; Anti-C3, rabbit antibody to human C3; Cl1P, first component of guinea pig complement; C29P, second component of guinea pig complement; C49P, fourth component of guinea pig complement; C4HU, fourth component of human complement; C3, third component of human complement; C3* Titer, the reciprocal of the dilution of human serum in EDTA which lyses 50% of a given concentration of EShACl42: this measures the combined function of the third through the ninth component; Cl-dependent pathway, the mechanism of activation of the terminal components (C3 and C5-C9) which depends upon the activation of Cl and subsequent activation of C4 and C2; CoF, cobra venom factor; EHUC3, human red cells coated with C3 (see text) ; EshC43HU, sheep cells coated with human C4 and C3; EShACl42, sensitized sheep red cells with the first, fourth, and second components of guinea pig complement attached; HANE, hereditary angioneurotic edema; PHN, paroxysmal nocturnal hemoglobinuria; VBS, (5, 6) , and activation of complement by inulin (7, 8) .
Complement activation in these procedures may occur by two different pathways. In the Cl-dependent pathway, antibody fixation effects the binding and activation of the first component of complement (Cl) which then activates the fourth (C4) and second (C2) components. The combination of C4 and C2 (C42 complex) cleaves the third component (C3) to an active fragment which leads to the activation of the terminal complement components (C5-C9) (9) .
Serum from patients with hereditary angioneurotic edema (HANE) lacks an inhibitor of the first component of complement (10) . In this serum, C1 is readily activated in the fluid phase and activation of C4 and C2 occurs, both in vivo and upon incubation in vitro. Subsequent depletion of C4 and C2 occurs without the functional depletion of the later complement components, C3-C9 (11). Thus, HANE serum cannot support Cl-dependent reactions.
C3 and the terminal components of the complement sequence may also be activated by an alternate mechanism which does not involve antibody or the Cl-dependent reactions. This alternate pathway, first described by Pillemer et al. (12) , may be activated by inulin, zymosan or other polysaccharides, and involves the complex interaction of several serum proteins which have not been well defined. This pathway also leads to cleavage of C3 and the activation of the terminal components of complement (13, 14) . The third component of complement assumes a central role when complement is activated by either pathway, since it is the first step of the final common sequence leading to cell lysis. C3 may be bound to the membrane of the red cell as a result of complement activation. Membrane-bound C3 may be detected by heterologous antibodies to native C3 (anti-C3). The amount of membrane-bound C3 may be measured by quantitating its interaction with anti-C3 (15, 16) .
In the present investigation, we have studied the mechanisms of complement activation and lysis in the five in vitro procedures used to detect the abnormal cells of PNH. Using HANE serum, we have determined whether the activation of the terminal steps of complement in each of these procedures occurs through the Cl-dependent pathway or through the alternate (properdin) path way.
We have measured the amount of membrane-bound C3 engendered by these procedures and have related this to the degree of lysis and to the mechanism of activation of the terminal steps of complement.
METHODS

Buffers and complement reagents
Veranol-buffered saline (VBS), isotonic sucrose buffer (VBSucrose), 60% isotonic sucrose-40% VBS (60% sucrose), buffered 0.015 M ethylenediaminetetracetic acid, disodium salt (EDTA-VB S), and Alsever's solution were prepared as outlined in reference (9) . Sheep red cells (E8"), rabbit antibody to boiled sheep red cell stromata (antiForssman antibody), guinea pig serum as a source of complement, the Cl and C2 from guinea pig serum and sensitized ESh with C49P on the surface (EShAC4) were prepared as previously described (9) . Highly purified human C3 and rabbit anti-C3 were prepared as described in reference 15. Partially purified cobra factor (CoF) was obtained from Sephadex G-100 chromatography as previously described (5) .
Human red cells and serum
Whole blood from normal donors and PNH patients was collected in an equal volume of Alsever's solution (17) and stored at 4VC until used. The red cells were washed thrice in VBS and resuspended in the appropriate buffer before use. Standard red cell suspensions containing 2.2 X 108 cells per cubic centimeter, prepared as described in reference 4, were used unless otherwise indicated.
Artificial PNH cells were prepared from normal cells by reaction with an 8%o solution (wt/vol) of aminoethylisothiouronium bromide (AET) for 9 min (18). The complement lysis sensitivity of these cells, assayed by the method of Rosse and Dacie (4), was increased 7-10 times.
To obtain normal human serum as a source of complement, blood, drawn aseptically, was immediately cooled and centrifuged at 0°C. The plasma was removed and maintained at room temperature until a fibrin clot had formed. (17) . The results of this assay of the terminal complement components, expressed as the reciprocal of the dilution of serum necessary to produce 50% lysis, are shown in Table I ; both normal and HANE serum retained full activity of the later complement components (C3 and C5-C9).
In vitro diagnostic tests for PNH 
Recovery of cells and stromata
After the in vitro lysis procedures, the amount of lysis was determined and the unlysed cells and the lysed cell stromata were recovered as follows: The incubation mixtures were centrifuged in a table-top centrifuge at 200 g for 2 min. The sedimented cells were resuspended in EDTA-VBS at 370C and again centrifuged slowly at 200 g. After the second centrifugation, the sedimented cells were washed thrice in 370C EDTA-VBS, twice in 370C VBS, and were resuspended in standard concentration in 60% sucrose.
To recover the stromata of complement lysed cells, the supernatant fluid from the first and second slow centrifugations were recentrifuged at 370C at 25,000 g for 15 min.
The supernatant fluid after centrifugation was analyzed for free hemoglobin by measuring absorbance at 412 or 541 nm. The fraction of cells lysed in the initial incubation (21) . Sheep 
RESULTS
The results of lysis of PNH cells in normal and HANE serum when treated with antibody, reduced ionic strength, acidification, inulin, and CoF are shown in Table II . Normal cells were not lysed in any of these procedures at the concentrations of reactants used. A portion of the PNH cells were lysed in all procedures when normal serum was used. When HANE serum was acidified or treated with CoF or inulin, lysis of PNH cells was not diminished. HANE serum did not support lysis of PNH cells by anti-I. When HANE serum was diluted in medium of reduced ionic strength, the degree of lysis of PNH cells was less than that seen in normal serum, especially at higher dilutions of serum (see Fig. 1 (Figs. 2-7 ). This did not appear to be an artifact of lysis since the same amount of antibody was detected whether the cells were intact or lysed by water, either before or after treatment with antibody and complement (Table III) . When cells were lysed with activated C3 proactivator (cobra venom lysis) and complement, and the washed membranes were then treated with antibody and more complement, the same amount of C3 was detected on the membranes as on the membranes of cells not lysed by activated C3 proactivator which were similarly treated with antibody and complement. Hence the increased C3 detectable on the membranes of lysed cells appears to be the result of the immune reaction and not due to an artifact of lysis or of the detection system. When normal and PNH cells were lysed by antibody and complement, more C3 is attached to the membranes of the lysed PNH cells than to the membranes of the lysed normal cells at a given concentration of antibody (when it is limiting) or complement (when it is limiting). The difference is most marked when antibody is is limiting and complement is in excess; three times as much C3 is fixed at low concentrations of antibody. The fixation of C3 to the unlysed PNH cells was greater than to unlysed normal cells when antibody was limiting, but was markedly less when complement was limiting; almost no C3 was attached to the unlysed PNH cells in these conditions (Fig. 4) . Differences in C3 binding could not be attributed to differences in the adsorption of antibody since the anti-I used in these experiments (Step.) was adsorbed equally to normal and PNH cells.
Although more C3 is attached to lysed PNH cells than to lysed normal cells for a given amount of antibody or complement, less C3 is required for a given amount (Fig. 8) In most instances, PNH cells bhid more C(3 than normal cells under the same conditions. This is especially true when complement is activated by limiting amounts of antibody. This increased C3 binding could not be attributed to increased binding of antibody since the anti-I used in these experiments is bound equally to normal and PNH cells. This increased binding of C3 may result from the membrane defect of PNH and may play a role in the remarkable susceptibility of these cells to lysis by complement.
The major effect of the membrane defect in PNH is, however, the remarkable susceptibility of these cells to lysis when small amounts of C3 are bound. When complement is activated by the alternate pathway or by reduced ionic strength, very small amounts of membranebound C3 appear to be necessary for lysis, even though, as pointed out above, large amounts may be bound. It is possible that the binding of C3 may be by-passed in these reactions since Lachmann and Thompson (26) have shown that fluid-phase activated C5, C6, and C7 might be responsible for passive ("reactive") lysis of cells.
When complement is activated by antibody, relatively larger amounts of C3 are required for lysis than when it is activated by the alternate pathway. This suggests that antibody-organized complement reactions are relatively less efficient in bringing about lysis than fluid-phase, alternate-pathway initiated reactions. Nevertheless, the amount of membrane-bound C3 required for lysis of PNH cells was clearly less than that required for lysis of normal cells.
AET-treated cells appear to share these membrane abnormalities with PNH. These cells are lysed as efficiently as PNH cells by very small amounts of membrane-bound C3 but fix lesser amounts of C3 than PNH cells for the same concentration of antibody or complement. The latter effect may account for the fact that these cells are not as sensitive to antibody-mediated complement lysis as PNH cells.
The increased sensitivity of PNH and AET-treated cells to the lytic action of complement may be due to several mechanisms: (a) one or more of the later components of complement may be attached in greater amount to these cells than to normal cells, (b) one or more of the later components of complement may be more effective in propagating the sequence or in effecting the ultimate lytic lesion, or, (c) both of these processes may occur. Gotze and Miiller-Eberhard (6) have adduced evidence that more C5 is attached to PNH cells than to normal cells, but each attached C5 is no more effective in causing lysis of PNH cells than of normal cells. The mechanism and the biochemical background for the increased lysis of PNH cells remains enigmatic.
